ENTITY
Jafron Biomedical

Jafron Biomedical (300529 CH)

19
Analysis
Health CareChina
Jafron Biomedical Co., Ltd. manufactures biomaterials and medical devices. The Company researches, produces, and sells immunization adsorption, resin hemoperfusion, blood purification, resin bandage, and other related products. Jafron Biomedical markets throughout China.
more
20 Jun 2025 18:10

Quiddity Leaderboard ChiNext & ChiNext 50 Dec25: ~US$600mn Collective One-Way Flows

We see US$366mn and US$231mn one-way flows for the ChiNext and ChiNext 50 rebalance events respectively. The ChiNext expected ADDs have strong...

Share
03 Jun 2025 21:00

Quiddity ChiNext/ChiNext 50 Jun25 Results: 23/26 Changes Correct Despite Methodology Change

We got 23 out of the 26 confirmed changes correct despite a last-minute change in methodology. We got all of the confirmed DELs correct. We had one...

Share
06 May 2025 14:15

Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: Last-Minute Methodology Changes; Final Expectations

There have been some last-minute changes to the index methodology which are expected to become effective during the June 2025 index rebal event. We...

Share
17 Apr 2025 17:50

Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: Some New Expectations; Try Sector-Neutral Pairs

There could be roughly US$1.4bn in total one-way flows for ChiNext and ChiNext 50 during the June 2025 index rebalance event. Some expectations...

Share
bullishTVS Motor
04 Jun 2023 05:55

Index Rebalance & ETF Flow Recap: CSI300/500, Chinext, China Semi Chips, Nifty Next50, SET50, REMX

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
707 Views
Share
x